India Cardiovascular Devices Market, By Type (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, and Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Cardiovascular Devices Market was valued at USD 1599.70 million in 2024 and is anticipated to reach USD 2427.89 Million by 2030, with a CAGR of 7.16% during 2025-2030. Cardiovascular devices constitute a broad category of medical equipment tailored to diagnose, monitor, treat, or manage conditions pertaining to the cardiovascular system, encompassing the heart and blood vessels. These devices play a pivotal role in the realm of cardiology, offering versatile applications ranging from diagnosing heart conditions to delivering life-saving interventions. In India, the aging demographic faces heightened susceptibility to cardiovascular diseases, necessitating a greater demand for cardiovascular devices and associated services. Continued technological advancements in the cardiovascular device sector have yielded more efficacious and sophisticated devices, propelling market expansion as healthcare providers strive to deliver cutting-edge care.

The escalating prevalence of cardiovascular diseases in India, such as heart disease and hypertension, serves as a key growth driver, fueling demand for cardiovascular devices for diagnostic and therapeutic purposes. Government-sponsored healthcare programs and initiatives targeting the mounting burden of cardiovascular ailments have the potential to further stimulate demand for cardiovascular devices by allocating funds for medical equipment and infrastructure enhancements. The proliferation of healthcare infrastructure, encompassing hospitals and specialized cardiac care centers, also contributes to market growth, as these facilities necessitate a diverse array of cardiovascular devices for comprehensive diagnosis and treatment protocols.

A burgeoning awareness of cardiovascular health in India, fostered by awareness campaigns, educational endeavors, and preventive measures, underscores the rising demand for diagnostic and monitoring devices tailored to cardiovascular health management. Regulatory dynamics and evolving standards governing medical devices in India exert a substantial influence on the approval and commercialization of cardiovascular devices. Manufacturers must adhere to these regulations to gain entry and thrive in the market landscape.

Key Report Takeaway

• Diagnostic and monitoring devices led the type segment in 2024, supported by widespread use of blood pressure monitors, ECG machines, and Holter monitors in clinics and homes
• Growing awareness of heart health, expansion of telemedicine, and rising home health care services increased the use of cardiac monitoring devices
• Coronary artery disease dominated the application segment, as high disease prevalence in India drives demand for imaging tools, angioplasty procedures, and coronary stents
• North India led regionally, supported by strong hospital infrastructure, higher income levels, a large patient base, and growth in medical tourism in cities such as Delhi

Key Market Drivers

Technological Advancements

Technological advancements are transforming India’s cardiovascular devices landscape by making diagnosis, intervention, and follow-up care more precise, less invasive, and more widely available across leading hospitals. Drug-eluting stents and advanced catheterization technologies are strengthening coronary care, with Abbott launching the XIENCE Sierra coronary stent in India and stating that it is also supporting cardiologists with AI-enabled imaging tools and diagnostics for complex interventions. For instance, Philips announced that it has crossed 1,500 cath lab installations in India and South Asia, highlighting the rapid expansion of image-guided therapy, IVUS, iFR, and hemodynamic monitoring capabilities that help clinicians assess coronary blockages with greater precision.

Robotic and minimally invasive cardiac procedures are also gaining momentum, as Apollo Hospitals Chennai reported completing 500 robotic cardiac procedures, showing how major private hospital groups are investing in technologies that can reduce surgical trauma and improve recovery. Alongside implantable devices, remote monitoring, AI-led analytics, and digitally connected cardiac platforms are helping care teams detect complications earlier, personalize treatment decisions, and improve efficiency, making technology one of the strongest growth drivers for cardiovascular devices in India.

Rising Aging Population

India’s rapidly expanding elderly population is becoming a major force behind cardiovascular device demand, with 149 million people aged 60 and above in 2022 and a projected 347 million by 2050, creating a larger pool of patients needing long-term cardiac diagnosis, monitoring, and intervention. The clinical burden is also intensifying with age, as cardiovascular diseases caused 28.1 percent of all deaths in India, 29.4 percent of adults aged 45 and above reported a cardiovascular condition, and heart attack prevalence rose from 2.1 percent at ages 45 to 49 to 8.2 percent at ages 80 to 84, while heart failure reached 3.5 percent in the 80 to 84 group. For instance, Apollo Hospitals Chennai has completed 500 robotic cardiac procedures, underscoring the growing adoption of minimally invasive, device-enabled cardiac care that can support quicker recovery in older patients.

Increasing Awareness and Prevention Efforts

Awareness campaigns and preventive measures are playing a central role in expanding cardiovascular device use in India by encouraging people to recognize warning signs early and track risk factors such as hypertension before they progress into serious cardiac events. This is strengthening demand for blood pressure monitors, ECG machines, and connected home-based monitoring tools, while also supporting telehealth-led follow-up and more personalized risk assessment in both urban and underserved settings. For instance, the Health Ministry reported that more than 38.9 crore people had been screened for hypertension under NPCDCS, with 5.13 crore diagnosed and 4.74 crore placed under treatment, while Omron said it sold about 1.6 million blood pressure monitors in India in FY2022 and sees demand rising to 14 million by FY2030 as home monitoring becomes more mainstream.

Download Free Sample Report

Key Market Challenges

Cost and Affordability

High device and procedure costs remain a major barrier in the India cardiovascular devices market, especially for lower- and middle-income patients who often must pay out of pocket for pacemakers, stents, valve implants, and advanced diagnostics, making timely intervention harder to access. The burden is amplified by incomplete insurance coverage, travel and lodging expenses for rural families seeking urban cardiac care, and strong import dependence, with more than 80 percent of critical implantables still imported and customs duties of 5 to 7.5 percent plus a 5 percent health cess adding to end-user prices.  

Import Dependence

India’s cardiovascular devices market remains highly exposed to imports, which leaves hospitals and patients vulnerable to foreign exchange swings, shipping delays, and pricing volatility for essential products such as implantable pacemakers, stents, and other advanced cardiac devices. More than 80 percent of critical implantables used in India are still imported, and the burden is further raised by customs duties of 5 to 7.5 percent along with a 5 percent health cess, making advanced cardiac care harder to afford for a wider patient base.

This dependence also reduces supply control and increases vulnerability during global trade disruptions, while differences in manufacturing standards across countries make strong regulatory oversight and quality checks especially important for patient safety. For instance, industry executives told ET Healthworld that structural heart procedures using multinational products can cost up to Rs 30 lakh, while Indian-made valves have reduced the expense by nearly half, showing how import reliance can directly shape both affordability and access in India’s cardiovascular device landscape.

Key Market Trends

Shift Towards Minimally Invasive Procedures

Minimally invasive procedures are becoming a strong driver of cardiovascular device adoption in India because patients increasingly prefer smaller incisions, less pain, shorter hospital stays, and faster recovery than traditional open-heart surgery can usually offer. These approaches also reduce physical trauma, scarring, and post-operative complications, which makes them especially valuable for older adults and people living with multiple comorbidities who need safer intervention pathways. At the same time, advances in catheters, imaging systems, and next-generation coronary stents are improving precision, deliverability, and access in complex lesions, helping expand the role of PCI and other less invasive cardiac interventions.

Segmental Insights

Type Insights

In 2024, the largest share of the India cardiovascular devices market was held by the diagnostic and monitoring devices segment and is expected to continue expanding in the coming years. Diagnostic and monitoring devices, such as blood pressure monitors, electrocardiogram machines and Holter monitors, are widely used in clinical settings and at home. Their broad adoption has helped this segment maintain its leading position.

Greater awareness of heart health and cardiovascular risk factors has led more people to monitor their heart health regularly. This includes routine blood pressure checks and electrocardiogram recordings, especially among people with risk factors such as hypertension and diabetes. The COVID-19 pandemic also accelerated telemedicine and remote monitoring in India, increasing the use of digital devices for cardiac monitoring.

The rise of home health care services has further increased demand for easy-to-use devices such as blood pressure monitors. India's aging population also faces a higher risk of cardiovascular disease, prompting many older adults and caregivers to use monitoring devices to manage and track heart health. Health care professionals rely on these devices for preliminary assessments, follow-up care and risk evaluation, making them essential to informed patient care decisions.

Application Insights

In 2024, the largest share of the India cardiovascular devices market was held by the coronary artery disease segment and is expected to continue expanding in the coming years. Coronary artery disease is one of the most prevalent cardiovascular conditions in India, particularly in urban and semi-urban areas. This high disease burden is driving demand for devices designed for the diagnosis and treatment of coronary artery disease.

The condition often requires advanced diagnostic tools, such as angiography machines, computed tomography angiography and intravascular ultrasound devices. These technologies help physicians diagnose the extent of coronary blockages, guide treatment decisions and assess outcomes. Coronary artery disease also frequently requires interventional procedures such as angioplasty and stent placement.

Demand remains strong for coronary stents, including drug-eluting stents, bare-metal stents and bioresorbable stents, because of the need for percutaneous coronary intervention in these patients. The segment also benefits from continued advances in imaging, catheter-based intervention and device materials, which are improving the safety and effectiveness of treatment. Lifestyle-related risk factors, including poor diet, physical inactivity, smoking and hypertension, continue to contribute to the high prevalence of coronary artery disease in India and often increase the need for medical intervention involving cardiovascular devices.

Download Free Sample Report

Regional Insights

North India dominated the India cardiovascular devices market in 2024. The region, particularly Delhi, has well-established health care infrastructure, including many leading hospitals and cardiac care centers. This concentration of high-quality medical facilities, equipped with advanced cardiovascular devices and technology, supports strong market demand.

North India is also one of the country's more economically prosperous regions. As a result, people in the region often have better access to health care services, including cardiovascular care. Higher average income levels can also increase demand for advanced cardiovascular devices and procedures.

The region is home to a significant share of India's population, including densely populated urban centers. This larger population base often corresponds with a higher prevalence of cardiovascular disease, driving demand for cardiovascular devices and treatment.

North India also hosts many prestigious educational and research institutions that often collaborate with health care facilities on research and development. These partnerships support innovation and encourage adoption of advanced cardiovascular technologies across the region.

Delhi and nearby areas are also popular destinations for medical tourism. International patients seeking cardiovascular care often choose the region for its advanced facilities and clinical expertise. This trend further increases demand for cardiovascular devices and related services.

Recent Developments

• In November 2025, Meril Life Sciences presented one-year outcomes from the LANDMARK randomized controlled trial for its indigenous Myval transcatheter heart valve series at PCR London Valves 2025. The trial covered 768 patients across 31 centres in 16 countries and directly compared Myval with leading international transcatheter valve platforms from Edwards Lifesciences and Medtronic under the same clinical conditions. The reported results were framed as a defining moment for Indian cardiovascular innovation because they showed an Indian-developed valve platform performing at par with established global systems in a high-rigor multicountry study.
• In October 2025, Abbott launched AVEIR DR in India, calling it the world’s first dual-chamber leadless pacemaker system. Abbott said its implant-to-implant wireless communication technology enables beat-to-beat coordination between two leadless pacemakers, while avoiding the leads and surgical pockets used in traditional systems. This counted as a breakthrough innovation in India’s cardiovascular devices space because it introduced a new minimally invasive pacing platform for cardiac rhythm management.
• In September 2025, Medtronic launched the Evolut FX+ transcatheter aortic valve in India for patients with severe aortic stenosis. Medtronic said the device was designed to improve future coronary access while maintaining the established performance of the Evolut platform, and noted that CDSCO approval had been granted in June 2025 before the India launch. The development added a next-generation TAVI option to India’s structural heart device segment, which is increasingly focused on minimally invasive valve replacement.
• In July 2025, AliveCor launched the Kardia 12L ECG system in India, describing it as the world’s first AI-powered handheld 12-lead ECG with a single-cable design. The CDSCO-approved device can detect 35 cardiac determinations, including acute myocardial infarction, ischemia, and multiple arrhythmias, and was positioned as a way to expand access to accurate heart data across a wide range of healthcare settings. This launch was important for India’s cardiovascular device market because it brought a more portable, AI-enabled diagnostic format into frontline cardiac care.

Key Market Players

• India Medtronic Pvt Ltd
• Siemens Healthcare Private Limited
• Boston Scientific Corporation
• Koninklijke Philips N.V.
• B. Braun Medical (India) Pvt. Ltd.
• Abbott India Limited
• Terumo India Private Limited
• Biotronik Medical Devices India Private Ltd.
• BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED

Report Scope:

In this report, the India Cardiovascular Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Cardiovascular Devices Market, By Type:

o   Diagnostic & Monitoring Devices

o   Surgical Devices

• India Cardiovascular Devices Market, By Application:

o   Coronary Artery Disease

o   Cardiac Arrhythmia

o   Heart Failure

o   Others

• India Cardiovascular Devices Market, By End-User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Others

• India Cardiovascular Devices Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Cardiovascular Devices Market.

Available Customizations:

India Cardiovascular Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Cardiovascular Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]